Engaging Key Stakeholders in New York to Drive Wider Adoption of NeuroVive
As part of the Global Explorers program, CardioCrown recently embarked on a project focused on exploring the use of its innovative neurorehabilitation platform, identifying both opportunities and barriers. This initiative allowed the team to conduct essential regulatory and market research, concluding in a valuable trip to New York, where they engaged directly with key stakeholders.
The Global Explorers programme, organised by Innovate UK, aims to support individual UK SMEs in exploring global research and development (R&D) and innovation opportunities. The programme offers successful applicants grant funding for 70% of eligible costs, up to £21,000, and provides access to a highly experienced Innovate UK Business Growth innovation and growth specialist. This unique opportunity enabled CardioCrown to gain insights into international collaboration and market access.
Victor Harabari, CEO of CardioCrown, shared his reflections on the trip, stating, “Engaging with stakeholders in New York has been an eye-opening experience. We were able to share our vision for NeuroVive and receive invaluable feedback that will help shape our approach as we work towards wider adoption of our platform. This direct engagement is crucial for understanding the market dynamics we need to navigate.”
The visit provided CardioCrown with the chance to connect with various stakeholders, fostering collaboration and generating interest in the Neurorehabilitation platform. This engagement is essential for building relationships that can accelerate the adoption of their innovative solutions.
Heralas Gaspariunas, co-founder of CardioCrown, added, “The opportunity to conduct regulatory and market research prior to our trip was instrumental in preparing us for these discussions. We’ve identified key barriers to entry and are now better equipped to address them. This program has opened new doors for us on an international scale.”
Through the Global Explorers programme, CardioCrown is excited to accelerate the development of its innovative Neurorehabilitation platform while forging essential international partnerships to drive global market access. The team is optimistic about the future and is committed to making a significant impact in the health tech sector.
